U.S. biotech company Moderna is aiming to begin manufacturing an unapproved coronavirus vaccine “as early as July,” CEO Stephane Bancel told CNBC.
The company has entered into a 10-year partnership with Swiss drugmaker Lonza to quickly move forward with manufacturing of the experimental vaccine mRNA-1273, which is now in a phase 1 human trial. The potential vaccine became the first candidate to enter a phase 1 trial in March, though the results of the trial have not yet been released, according to a report by CNBC’s Will Feuer. —Hannah Miller
https://www.cnbc.com/quotes/?symbol=MRNA
Where is my STRONG BUY button?!!! Ah here:
The company has entered into a 10-year partnership with Swiss drugmaker Lonza to quickly move forward with manufacturing of the experimental vaccine mRNA-1273, which is now in a phase 1 human trial. The potential vaccine became the first candidate to enter a phase 1 trial in March, though the results of the trial have not yet been released, according to a report by CNBC’s Will Feuer. —Hannah Miller
https://www.cnbc.com/quotes/?symbol=MRNA
Where is my STRONG BUY button?!!! Ah here:
